Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,712 total articles
Polaris (PII) is a cash-generative recreational products franchise with a 4.2% yield, a large addressable UTV/marine market tailwind and recent operational wins that should support a multi-month recovery. The stock is trading below key moving averages and at a sub-1x price-to-sales multiple. We lay out an actionable long trade with entry, stop and …
Tuya ($1.76) looks set to benefit from accelerating adoption of its AI Agent and Hey Tuya assistant, improving technical momentum, and a sub-$1.1B market cap that leaves room for a re-rating if growth steadies. This trade idea lays out an actionable entry at $1.76, a stop at $1.59, and a target of $2.40 over a mid-term 45 trading day horizon, with …
Supermicro (SMCI) has been hit hard but the core business - high-performance servers and AI-optimized systems - still sits on a favorable secular runway. With shares well off prior highs and a rebound in AI spending increasingly visible, this is a tactical long idea for disciplined traders willing to accept execution risk and near-term cyclicity.
KLA is uniquely exposed to the semiconductor equipment sweet spot driving capital spending into 2027: metrology/inspection for advanced packaging and a multi-year memory/AI-capex cycle. Strong free cash flow ($3.77B), exceptional ROE (76%), and an improving revenue mix justify a long-term swing trade, even after a high P/E. Enter around $183, stop …
<p>CoreWeave is positioned as a high-growth GPU cloud specialized for AI workloads. Recent pricing action from Nvidia that raises GPU list prices is widely seen as a headwind for cloud users and smaller GPU resellers. I argue it can be a net positive for CoreWeave: price hikes favor providers with scale, deep vendor relationships, and differentiate…
Fiserv (FISV) trades at ~10x earnings and an EV/EBITDA of ~7.2 with free cash flow near $3.93B. Recent activist involvement, a CEO transition, and possible asset monetizations (including the Clover business) create a clear path to earnings upside and multiple expansion. I favor a long trade at current levels with a $75 target over the next 180 trad…
Immatics (IMTX) is a clinical-stage TCR developer with anzu-cel (IMA203) nearing a regulatory milestone: the Phase 3 SUPRAME program is on track for a BLA submission in H1 2027. Recent Phase 1b data showed a 56% confirmed ORR and durable responses, supporting a binary catalyst that could re-rate the $1.25B market-cap equity. This trade sets a clear…
Compass Pathways (CMPS) is a high-volatility biotech with positive Phase 3 data and favorable regulatory momentum in 2026. The stock trades near $14.86 with a market cap around $2.0B. This trade idea outlines a mid-term swing long (45 trading days) with an entry at $14.86, stop at $11.50, and a target of $20.00 while mapping the clinical, regulator…
Nano Labs (NA) trades like a microcap semiconductor turnaround while carrying a sub-$50M market cap, single-digit P/E, and recent insider buying. Technicals show improving momentum and short sellers active — a recipe for volatile upside. We lay out a trade plan for a mid-term (45 trading days) swing that targets a rerating back toward more reasonab…
Vistra has the assets, signed long-term PPAs with hyperscalers, and improving profitability. The stock is trading at $139 and still reflects near-term supply fears and weak technicals, but not the locked-in earnings upside from recent contracts. This trade buys that disconnect with a mid-term horizon and a clear stop-loss.
Nebius has moved from hype to execution: Q2-level growth, multi-hundred percent revenue expansion, and a materially improved payback period. The market is demanding perfection given a $59.8B valuation, but the company’s recent contract cadence and improving unit economics create a defined asymmetric trade. Entry at $220, stop at $195 and a $300 tar…
Compass Pathways (CMPS) remains a buy after positive Phase 3 data and regulatory tailwinds, but its rally and high valuation require tighter risk control. Market cap sits near $2.02B with the stock trading at $14.87, close to its 52-week high of $15.40. This trade plan uses a measured entry, a protective stop and a two-stage target to capture upsid…
SK hynix is a core memory-cycle play. After a historic boom in DRAM and NAND, the stock has retraced while industry unit demand and AI-driven memory intensity continue to underpin a recovery. This trade targets a recovery toward value-normalized multiples with a clear stop and staged horizon plan.
Navitas (NVTS) is repositioning from mobile/consumer GaN into high-power AI data-center and eMobility markets. The repositioning creates a near-term headline-driven ride but also a multi-quarter fundamental opportunity if the company converts design wins into revenue. This trade idea outlines a disciplined long swing with a clear entry, stop and ta…
Microsoft's AI-led growth story remains intact: durable cloud momentum, product-led monetization via Copilot, and ample balance-sheet optionality. This trade idea lays out a long trade with specific entry, target and stop, a rationale tied to fundamentals and catalysts, and a risk framework that could flip the thesis.
Comcast shares have slipped from earlier 2026 highs, but the stock still trades at a single-digit P/E and generates roughly $20.4B of free cash flow. With a near-5% dividend yield, an NBCUniversal spinoff on the horizon and attractive valuation multiples (EV/EBITDA ~5.2x, P/FCF ~4.7x), I view the recent sell-off as an overreaction and recommend a t…
BYD's export momentum and improving market dynamics support a mid-term long trade in BYDDF. Technicals are constructive, short interest has fallen sharply since spring, and recent intraday strength shows buyers willing to defend $12. Trade plan: enter $11.95, stop $10.95, target $14.50 for a mid-term (45 trading days) swing.
Northrop Grumman is a direct beneficiary of rising missile defense, space modernization and autonomous warfare budgets. At $543.69, the stock trades at ~17x earnings with $3.65B of free cash flow and a $77.2B market cap, offering a risk/reward profile attractive for a mid-term directional trade. This idea outlines an entry, stop, targets and the fu…
Slide Insurance is trading at a single-digit P/E with robust cash generation and minimal leverage. The company reported $1.16B in revenue (+36% YoY) and $444M in net income; with free cash flow over $1B and EV/Sales ~1.12, the market is overlooking upside from rate hardening in catastrophe-exposed markets. This trade targets a re-rating into late-s…
Equinix sits squarely in the path of rising AI inference demand. With a market cap around $107B, premium multiples, and improving technical momentum, EQIX looks set to benefit from hyperscale GPU density and enterprise colocation growth. This trade idea lays out an actionable mid-term long: entry at $1086.00, target $1200.00, stop $1000.00, horizon…
Iberdrola's ADR is trading at $94.05 with technicals showing consolidation around the 10-day and 21-day averages and growing short interest. We view a mid-term swing trade as attractive: entry at $94.05, target $110.00, stop loss $87.00. Catalysts include stronger Spanish GDP, continued renewable project wins, and policy support for green hydrogen …
Green Plains (GPRE) looks like a tactical long as commodity and policy dynamics tilt bullish for ethanol and carbon capture assets. At roughly $14.93, the stock trades with single-digit P/E and attractive EV/EBITDA while technicals show room to run if sentiment flips. This trade idea lays out a mid-term (45 trading days) plan with entry, stop and a…
Fossil has stabilized around the mid-$5s after a prolonged restructuring and debt overhaul. Reduced promotional activity, inclusion in the Russell 2000 and a possible India IPO create a credible path for earnings recovery and multiple expansion. This trade targets a move toward $8 over the next 180 trading days with a disciplined stop below $4.40.
Taiwan Semiconductor (TSM) remains the backbone of the AI semiconductor supply chain. With a $2.16T market cap, ~72-73% share of third-party foundry spending, and customers (notably Nvidia) driving outsized demand, TSM is positioned to benefit as hyperscalers and cloud players scale custom silicon. This is a measured long trade: enter near $415.70,…
Immunic's oral immunology pipeline — anchored by vidofludimus calcium and supported by IMU-935 and IMU-856 — looks primed for renewed market attention. At $16.78, the stock trades closer to a cash-adjusted enterprise value than to a growth-stage peer multiple. With compelling technicals, compressed float and upcoming catalysts, this is a tactical l…
